The invention is directed to to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
本发明涉及式(I)化合物及其盐。该发明的化合物是PI3-激酶活性的抑制剂。
Compounds
申请人:Baldwin Ian Robert
公开号:US08765743B2
公开(公告)日:2014-07-01
The invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
这项发明涉及公式(I)化合物及其盐。该发明的化合物是PI3-激酶活性的抑制剂。
NOVEL COMPOUNDS
申请人:Glaxo Group Limited
公开号:EP2280959A1
公开(公告)日:2011-02-09
US8765743B2
申请人:——
公开号:US8765743B2
公开(公告)日:2014-07-01
[EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
申请人:GLAXO GROUP LTD
公开号:WO2009147190A1
公开(公告)日:2009-12-10
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.